Sonexa Therapeutics, Inc. (extinct)

Sonexa Therapeutics, Inc. (extinct)

Sonexa Therapeutics, Inc. (extinct)

Overview
Date Founded

2008

Headquarters

12481 High Bluff Drive,Suite 150,San Diego, CA 92130

Type of Company

Private

Employees (Worldwide)

1 - 10

Industries

Pharmaceuticals
Biotechnology

Company Description

Sonexa Therapeutics, Inc. developed drug treatments for Alzheimer's disease (AD) and related disorders. Its lead compound, ST101 had demonstrated both the cognitive benefits of currently marketed AD treatments along with significant disease modifying effects. The company was founded in January 2008 and was headquartered in San Diego, CA.

Paths to Sonexa Therapeutics, Inc.
Potential Connections via
Relationship Science
You
Sonexa Therapeutics, Inc.
Recent Transactions
Details Hidden

Sonexa Therapeutics, Inc. raised money in a private placement transaction

Details Hidden

Sonexa Therapeutics, Inc. raised money in a private placement transaction

Details Hidden

Sonexa Therapeutics, Inc. raised money in a private placement transaction

Investors
Details Hidden

Member, Clinical Advisory Board at Cognoptix, Inc.

Details Hidden

Alta Partners Management Corp. specializes in investments in healthcare venture capital companies. The firm looks for Technology enabled solutions and services that improve delivery and quality of care with Strong entrepreneurs

Details Hidden

Domain Associates invests exclusively in emerging life sciences companies. The firm focuses on pharmaceuticals, specialty pharmaceuticals and medical devices and they are also interested in biomaterials, bioinstrumentation and diagnostics. They prefer to be part of the first institutional financing round of a company. They look for companies with outstanding technology addressing unmet needs in very large markets led by exceptional management. Once invested, Domain takes an active role in guiding the growth of the company. They take a seat on the Board of Directors in the vast majority of cases. Most of their investments are in private companies, but they also invest in small-cap public healthcare companies that are implementing a new corporate strategy.

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Sonexa Therapeutics, Inc.. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Sonexa Therapeutics, Inc.'s profile does not indicate a business or promotional relationship of any kind between RelSci and Sonexa Therapeutics, Inc..